Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C30H55NO11 |
| Molecular Weight | 605.7578 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 15 / 15 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC[C@H]1OC(=O)[C@H](C)[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C(C)=O)[C@](C)(O)C[C@@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@]1(C)O
InChI
InChIKey=YYAIHIDSVFXXHN-CIHMTEDYSA-N
InChI=1S/C30H55NO11/c1-11-21-30(9,39)25(36)16(4)22(33)14(2)13-29(8,38)26(17(5)23(34)18(6)27(37)41-21)42-28-24(35)20(12-15(3)40-28)31(10)19(7)32/h14-18,20-26,28,33-36,38-39H,11-13H2,1-10H3/t14-,15-,16+,17+,18-,20+,21-,22+,23+,24-,25-,26-,28+,29-,30-/m1/s1
| Molecular Formula | C30H55NO11 |
| Molecular Weight | 605.7578 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 15 / 15 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Tue Apr 01 16:31:34 GMT 2025
by
admin
on
Tue Apr 01 16:31:34 GMT 2025
|
| Record UNII |
5P8VR47M4P
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
654076-73-0
Created by
admin on Tue Apr 01 16:31:34 GMT 2025 , Edited by admin on Tue Apr 01 16:31:34 GMT 2025
|
PRIMARY | |||
|
5P8VR47M4P
Created by
admin on Tue Apr 01 16:31:34 GMT 2025 , Edited by admin on Tue Apr 01 16:31:34 GMT 2025
|
PRIMARY | |||
|
11505364
Created by
admin on Tue Apr 01 16:31:34 GMT 2025 , Edited by admin on Tue Apr 01 16:31:34 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
Class: Macrolide; Mechanism of Action: Undefined mechanism; Highest Development Phase: Phase I for Inflammation; Most Recent Events: 06 Sep 2004 Data presented at the 18th International Symposium of Medicinal Chemistry (ISMC-2004) have been added to the adverse events, pharmacokinetics and Inflammation pharmacodynamics sections, 29 Jul 2004 Preclinical trials in Chronic obstructive pulmonary disease in Europe (unspecified route)
|